Kidney Week

Abstract: FR-PO058

Comparison of Clinical Characteristics of AKI between Glufosinate and Glyphosate Poisoning

Session Information

• AKI: Epidemiology, Risk Factors, and Prevention - 2
  October 25, 2024 | Location: Exhibit Hall, Convention Center
  Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

• 101 AKI: Epidemiology, Risk Factors, and Prevention

Authors

• Oh, Ju hwan, Presbyterian Medical Center, Jeonju, Jeollabuk-do , Korea (the Republic of)

Ju hwan Oh, MD

• Cho, A young, Presbyterian Medical Center, Jeonju, Jeollabuk-do , Korea (the Republic of)

A young Cho, MD

• Lee, Haeun, Presbyterian Medical Center, Jeonju, Jeollabuk-do , Korea (the Republic of)

Haeun Lee, MD

• Sun, In O, Presbyterian Medical Center, Jeonju, Jeollabuk-do , Korea (the Republic of)

In O Sun, MD, PhD

Background

There are few studies comparing the clinical characteristics of acute kidney injury (AKI) between glufoinate and glyphosate poisoning. In this study, we investigated the clinical characteristics of AKI in patients with glufosinate and glyphosate poisoning, and compared the clinical features of AKI between two groups.

Methods

This study performed between 2008 and 2021 included 76 patients with glufosinate poisoning and 184 patients with glyphosate poisoning. This study included 76 patients with glufosinate poisoning and 184 patients with glyphosate poisoning in the period from 2008 to 2021. Based on Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease classification, we investigated the incidence, clinical characteristics, and severity of AKI between two groups [(glufosinate-induced AKI (Glu-AKI, n=54) and glyphosate-induced AKI (Gly-AKI, n=82)].

Results

The incidence of AKI in patients with glufosinate poisoining is higher than that of glyphosate poisoning (57.5% vs 44.5%, P<0.05). However, there is no difference of AKI severity between two groups (Glu-AKI; Risk 56.2%, Injury 36.9%, Failure 6.9% vs Gly-AKI; Risk 56.2%, Injury 14.6%, Failure 29.2%, P=NS). Comparing two groups, there is also no difference in age (62.6±14.2 years vs. 63.3±16.2 years, P=NS) and renal function on admission (63.9±25.2 mL/min/1.73 m² vs. 62.2±22.9 mL/min/1.73 m^2, P=NS). The length of hospitalization was longer (17.2±17.2 days vs. 10.7±12.1 days, P<0.05) in Glu-AKI group than that of Gly-AKI group. The mortality rate was higher in the Gly-AKI group than Glu-AKI (11.1% vs. 18.3%, P=NS). Multivariate logistic regression analysis showed that serum bicarbonate concentration on admission was a significant predictors of AKI in patients with AKI after glyphosate and glufosinate intoxication

Conclusion

Although there is a higher incidence of AKI in glufosinate poisoning, there is no difference in clinical characteristics between the two types of intoxication.